subject: CHEBI:26710

object_name: chronic kidney disease


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Chronic uremia

tested_intervention: yes


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: arthroplasty; complications

tested_intervention: unsure


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10034

subject_name: warfarin sodium


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Ovarian cancer stage IV


subject: UNII:DPT0O3T46P

object_name: malignant neoplasm of ovary stage IV


subject: PUBCHEM.COMPOUND:284240

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:284240

object_name: breast neoplasm


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: Prediabetes


subject: UMLS:C0885467

object_name: Overweight and obesity


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Nausea post chemotherapy


subject: CHEBI:499361

object_name: head and neck cancer


subject: UNII:R581OT55EA

subject_name: PEG-uricase

object_name: tumor lysis syndrome


subject: UNII:R581OT55EA

object_name: Tumor Lysis Syndrome, CTCAE 3.0


subject: UNII:R581OT55EA

object_name: Tumor Lysis Syndrome, CTCAE 5.0


subject: UNII:R581OT55EA

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:R581OT55EA

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:R581OT55EA

object_name: Malignant Solid Neoplasm


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED


subject: UMLS:C1314420


subject: UMLS:C1314420


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: CHEBI:184662

object_name: AIDS dementia


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:72296

subject_name: Apixaban

object_name: thrombocytopenia


subject: CHEBI:72296

object_name: Pulmonary embolism and thrombosis


subject: UMLS:C1831911

object_name: pancreatic neoplasm


subject: UMLS:C1831911

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1831911

object_name: malignant pancreatic neoplasm


subject: UMLS:C1831911

object_name: renal carcinoma


subject: UMLS:C1831911

object_name: kidney neoplasm


subject: UMLS:C1831911

object_name: kidney cancer


subject: UMLS:C1831911

object_name: liver cancer


subject: UMLS:C1831911

object_name: liver neoplasm


subject: UMLS:C1831911

object_name: Adult Liver Carcinoma


subject: UMLS:C1831911

object_name: liver carcinoma


subject: UMLS:C1831911

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831911

object_name: breast carcinoma


subject: UMLS:C1831911

object_name: breast cancer


subject: UMLS:C1831911

object_name: ovarian cancer


subject: UMLS:C1831911

object_name: ovarian neoplasm


subject: UMLS:C1831911

object_name: ovarian carcinoma


subject: UMLS:C1831911

object_name: colorectal cancer


subject: UMLS:C1831911

object_name: colorectal carcinoma


subject: UMLS:C1831911

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1831911

object_name: digestive system cancer


subject: UMLS:C1831911

object_name: adrenal carcinoma


subject: UMLS:C1831911

object_name: adrenal cortex carcinoma


subject: UMLS:C1831911

object_name: skin melanoma


subject: UMLS:C1831911

object_name: malignant soft tissue neoplasm


subject: UMLS:C1831911

object_name: sarcoma


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:145371

object_name: Unresectable Carcinoma


subject: CHEBI:145371

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:8499

subject_name: Propranolol

object_name: labor; poor


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: coronary artery disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: hypoglycemia


subject: CHEBI:6801

object_name: Blood glucose below reference range (finding)


subject: CHEBI:6801

object_name: Hypoglycemia, CTCAE


subject: CHEBI:5383

subject_name: Glimepiride


subject: CHEBI:5383


subject: CHEBI:5383


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: obstructive jaundice


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: glioblastoma


subject: CHEBI:141969

object_name: Brain Stem Glioblastoma


subject: CHEBI:141969

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: UMLS:C0393031


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Non-Hodgkin's lymphoma refractory


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:CER0OPG92L

subject_name: Abivertinib


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: primary brain neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Chronic kidney disease, Stage V


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Metastatic Uveal Melanoma


subject: UMLS:C3827149


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Cardiac amyloidosis


subject: UMLS:C0001645

object_name: Transthyretin cardiac amyloidosis


subject: CHEBI:9927

subject_name: Valsartan

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:9927

object_name: obesity


subject: CHEBI:9927

object_name: Obesity, CTCAE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:52763


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Chest Wall Disorder


subject: UNII:DPT0O3T46P


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:WP6PY72ZH3

subject_name: Motolimod

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:WP6PY72ZH3

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:WP6PY72ZH3

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:WP6PY72ZH3

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:WP6PY72ZH3

object_name: salivary gland squamous cell carcinoma


subject: UNII:WP6PY72ZH3

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:WP6PY72ZH3

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:WP6PY72ZH3

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:WP6PY72ZH3

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:WP6PY72ZH3

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:WP6PY72ZH3

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:WP6PY72ZH3

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:WP6PY72ZH3

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UNII:WP6PY72ZH3

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:WP6PY72ZH3

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UNII:WP6PY72ZH3

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:WP6PY72ZH3

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UNII:WP6PY72ZH3

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:WP6PY72ZH3

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UNII:WP6PY72ZH3

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:WP6PY72ZH3

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:WP6PY72ZH3

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:WP6PY72ZH3

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:WP6PY72ZH3

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:WP6PY72ZH3

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:WP6PY72ZH3

object_name: Recurrent Salivary Gland Cancer


subject: UNII:WP6PY72ZH3

object_name: tongue cancer


subject: UNII:WP6PY72ZH3

object_name: tongue carcinoma


subject: UNII:WP6PY72ZH3

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVC verrucous carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVA verrucous carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:WP6PY72ZH3

object_name: Laryngeal verrucous carcinoma stage III


subject: UNII:WP6PY72ZH3

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:WP6PY72ZH3

object_name: stage IVB verrucous carcinoma of the larynx


subject: UNII:WP6PY72ZH3

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UNII:WP6PY72ZH3

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UNII:WP6PY72ZH3

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UNII:WP6PY72ZH3

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:WP6PY72ZH3

object_name: Salivary gland cancer stage IV


subject: UNII:WP6PY72ZH3

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:WP6PY72ZH3

object_name: Salivary gland cancer stage III


subject: UNII:WP6PY72ZH3

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:3757

subject_name: Clonidine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:3757


subject: CHEBI:31355

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:135483998

object_name: renal hypertension


subject: PUBCHEM.COMPOUND:135483998

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:135483998

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:135402010


subject: PUBCHEM.COMPOUND:135402010


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:136009


subject: CHEBI:136009


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: urgency urinary incontinence


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: primary cutaneous lymphoma


subject: UNII:7XL5ISS668

object_name: Cutaneous lymphoma


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: superficial urinary bladder carcinoma


subject: UNII:Y6BX7BL23K

object_name: bladder tumor


subject: UNII:Y6BX7BL23K

object_name: urinary bladder carcinoma


subject: UNII:Y6BX7BL23K

object_name: urinary bladder cancer


subject: UNII:Y6BX7BL23K

object_name: childhood bladder carcinoma


subject: UNII:Y6BX7BL23K

object_name: Urothelial carcinoma recurrent


subject: UMLS:C0211023

object_name: ovarian carcinoma


subject: UMLS:C0211023

object_name: malignant epithelial tumor of ovary


subject: CHEBI:6121

subject_name: Ketamine

object_name: Caesarean section


subject: CHEBI:6121

object_name: perinatal asphyxia


subject: CHEBI:6121

object_name: Perinatal depression in mother


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Therapy Object (animal model)


subject: CHEBI:8427

subject_name: Probucol


subject: CHEBI:23359

subject_name: colchicine

object_name: Postpericardiotomy Syndrome


subject: CHEBI:23359

object_name: Pleural effusion


subject: CHEBI:23359

object_name: Pleural Effusion, CTCAE


subject: CHEBI:23359

object_name: x-ray of chest: pleural effusion


subject: UMLS:C0010347

subject_name: cromoglycate

object_name: psoriasis


subject: CHEBI:59773

subject_name: CROMOLYN


subject: CHEBI:90227

subject_name: Selumetinib

object_name: low grade glioma


subject: CHEBI:90227

object_name: Refractory Visual Pathway Glioma


subject: CHEBI:90227

object_name: Recurrent Visual Pathway Glioma


subject: CHEBI:90227

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:90227

object_name: Refractory Neurofibromatosis Type 1


subject: CHEBI:90227

object_name: Recurrent Neurofibromatosis Type 1


subject: CHEBI:90227

object_name: Recurrent Childhood Pilocytic Astrocytoma


subject: UMLS:C3896750

object_name: Primary Sjögren's syndrome


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: liver cirrhosis


subject: UNII:D5ZJ707VIR

subject_name: LICAMINLIMAB

object_name: dry eye syndrome


subject: UMLS:C5555469

subject_name: Licaminlimab


subject: CHEBI:74705

subject_name: Met-Leu

object_name: postmenopausal osteoporosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Intracerebral Hemorrhagic Stroke


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C4535511

subject_name: muscadine grape extract

object_name: Prostate cancer recurrent


subject: UNII:3HP012Q0FH

object_name: retinal vein occlusion


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UNII:JTZ51LIXN4

subject_name: NEMTABRUTINIB

object_name: follicular lymphoma


subject: UNII:JTZ51LIXN4

object_name: mantle cell lymphoma


subject: DRUGBANK:DB18866

subject_name: Nemtabrutinib


subject: DRUGBANK:DB18866


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN


subject: UNII:IZY9ZSI6FI

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:IZY9ZSI6FI


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: Fatigue, CTCAE 5.0


subject: UNII:3ZY6J6Z6EE

object_name: Fatigue


subject: UNII:3ZY6J6Z6EE

object_name: Parkinsonism


subject: UMLS:C4687517

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C4687517

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4687517

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UMLS:C4053601


subject: CHEBI:36080

subject_name: protein

object_name: head and neck neoplasm


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:16919

subject_name: Creatine


subject: GTOPDB:8926

subject_name: glembatumumab vedotin

object_name: metastatic melanoma


subject: GTOPDB:8926


subject: GTOPDB:8926


subject: GTOPDB:8926

object_name: Unresectable Solid Neoplasm


subject: GTOPDB:8926

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:8926

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: GTOPDB:8926

object_name: Stage III Breast Cancer AJCC v7


subject: GTOPDB:8926

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: GTOPDB:8926

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: GTOPDB:8926

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: GTOPDB:8926

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: GTOPDB:8926

object_name: triple-negative breast carcinoma


subject: GTOPDB:8926

object_name: Progesterone Receptor Negative


subject: GTOPDB:8926

object_name: Stage III Uveal Melanoma AJCC v7


subject: GTOPDB:8926

object_name: Estrogen Receptor Negative


subject: GTOPDB:8926

object_name: HER2/Neu Negative


subject: GTOPDB:8926

object_name: GPNMB Positive


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:1568H6A58U

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UNII:1568H6A58U


subject: UMLS:C2698156

object_name: metastatic melanoma


subject: UMLS:C2698156


subject: UMLS:C2698156


subject: UMLS:C2698156

object_name: Unresectable Solid Neoplasm


subject: UMLS:C2698156

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2698156

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2698156

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C2698156

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: UMLS:C2698156

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UMLS:C2698156

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C2698156

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C2698156

object_name: triple-negative breast carcinoma


subject: UMLS:C2698156

object_name: Progesterone Receptor Negative


subject: UMLS:C2698156

object_name: Stage III Uveal Melanoma AJCC v7


subject: UMLS:C2698156

object_name: Estrogen Receptor Negative


subject: UMLS:C2698156

object_name: HER2/Neu Negative


subject: UMLS:C2698156

object_name: GPNMB Positive


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:3035406

object_name: septic shock


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: High Grade Sarcoma


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Surgical Wound Infection


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C5706466

subject_name: Cathepsin-targeted Fluorescent Imaging Probe VGT-309

object_name: colorectal cancer


subject: UMLS:C5706466

object_name: colorectal carcinoma


subject: UMLS:C5706466

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: retinitis pigmentosa


subject: CHEBI:168243

object_name: retinitis pigmentosa 1


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:6775

subject_name: Mesalazine

object_name: diverticulitis


subject: CHEBI:142432

subject_name: Vericiguat

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:142432

object_name: metabolic syndrome X


subject: CHEBI:142432

object_name: Coronary microvascular dysfunction


subject: CHEBI:91414

subject_name: Adavosertib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:91414

object_name: acute myeloid leukemia


subject: CHEBI:91414

object_name: Refractory acute myeloid leukemia


subject: CHEBI:91414

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:91414

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:91414

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:91414

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:91414

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:91414

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91414

object_name: Blast Phase


subject: CHEBI:91414

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91414

object_name: Myelodysplasia


subject: CHEBI:91414

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:91414

object_name: childhood myelodysplastic syndrome


subject: CHEBI:91414

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:94531

subject_name: belinostat


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:94531


subject: CHEBI:63043

object_name: heart failure


subject: CHEBI:63043

object_name: Heart Failure, CTCAE


subject: GTOPDB:7487

subject_name: alpha1-proteinase inhibitor


subject: GTOPDB:7487

object_name: viral pneumonia


subject: UMLS:C0795657

subject_name: Aralast


subject: UMLS:C0795657


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C0002191


subject: PR:000016196

object_name: no feeling or sensation of skin


subject: PR:000016196

object_name: Sensory Loss


subject: PR:000016196

object_name: Hemodynamic instability


subject: PR:000009987

subject_name: latexin


subject: PR:000009987


subject: PR:000009987


subject: UNII:83U7957287

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:28918

subject_name: Epinephrine

object_name: cataract


subject: CHEBI:28918

object_name: Cataract, CTCAE 3.0


subject: CHEBI:28918

object_name: Cataract, CTCAE 5.0


subject: CHEBI:28918

object_name: cataract on exam (physical finding)


subject: UMLS:C1963284

subject_name: Adrenalin


subject: UMLS:C1963284


subject: UMLS:C1963284


subject: UMLS:C1963284


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline

object_name: Bacterial sepsis


subject: UNII:07896928ZC


subject: PUBCHEM.COMPOUND:3417

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:3417


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: UMLS:C2095775

subject_name: ampicillins


subject: UMLS:C2095775


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam


subject: PUBCHEM.COMPOUND:5316


subject: UNII:E8I3O45DDU

object_name: diabetic cardiomyopathy


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: sickle cell-hemoglobin c disease syndrome


subject: UMLS:C5667050

subject_name: Anti-CD20/anti-CD3 Bispecific Antibody CM355

object_name: hematoma


subject: UMLS:C5667050

object_name: Hematoma, CTCAE


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: adult acute myeloid leukemia


subject: CHEBI:197437

object_name: childhood acute myeloid leukemia


subject: CHEBI:197437

object_name: acute myeloid leukemia


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: UMLS:C4048878


subject: UMLS:C4048878


subject: PUBCHEM.COMPOUND:131648253

subject_name: PEN

object_name: migraine


subject: PUBCHEM.COMPOUND:131648253

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:66Q80IL7CW

subject_name: Penclomedine


subject: UNII:66Q80IL7CW


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Ibrutinib Resistance


subject: CHEBI:133021

subject_name: Venetoclax


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: cancer of unknown primary site


subject: UNII:308PA1L567

subject_name: Endoxifen Hydrochloride

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:308PA1L567

object_name: Stage IIIA Breast Carcinoma


subject: UNII:308PA1L567

object_name: Stage IIIB Breast Carcinoma


subject: UNII:308PA1L567

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:308PA1L567

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:308PA1L567

object_name: Breast cancer recurrent


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:90926

subject_name: Tenofovir alafenamide

object_name: Transplant present


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:70839

object_name: Rectal cancer stage IV


subject: CHEBI:70839

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:70839

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:70839

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:70839

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pulmonary embolism


subject: CHEBI:73604

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:73604

object_name: Deep venous thrombosis


subject: GTOPDB:8257

subject_name: sifalimumab

object_name: EXCESS LMW-DNA


subject: UNII:XOY1YA7RMC


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection

object_name: peripheral arterial disease


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:17303

subject_name: Morphine

object_name: chronic diarrheal disease


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 4


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 7


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 6


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 2


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 8


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 9


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 1


subject: PUBCHEM.COMPOUND:521372

object_name: major affective disorder 5


subject: UMLS:C5418052

subject_name: Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5418052

object_name: Advanced cancer


subject: UMLS:C5418052

object_name: triple-negative breast carcinoma


subject: UMLS:C5418052

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1709429


subject: UMLS:C2092204

subject_name: Aminophylline Liquid Injection

object_name: third-degree atrioventricular block


subject: UMLS:C2092204

object_name: AV Block Third Degree by ECG Finding


subject: UMLS:C2092204

object_name: inferior myocardial infarction


subject: UMLS:C2092204

object_name: Inferior Myocardial Infarction by ECG Finding


subject: CHEBI:2659

subject_name: Aminophylline


subject: CHEBI:2659


subject: CHEBI:2659


subject: CHEBI:2659


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: traumatic brain injury


subject: UMLS:C1883272

subject_name: Folate Receptor-Targeted Technetium Tc-99m EC20

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C1883272

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: musculoskeletal system disorder


subject: CHEBI:64045

subject_name: Amisulpride

object_name: treatment-refractory schizophrenia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Cardiovascular insufficiency


subject: CHEBI:17650

object_name: Neonatal disorder


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: prostatitis


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: cervical cancer


subject: MESH:C496822

subject_name: xuezhikang

object_name: hypertension


subject: MESH:C496822

object_name: Hypertension, CTCAE


subject: CHEBI:231891


subject: CHEBI:231891


subject: CHEBI:77260

subject_name: Omeprazole

object_name: systemic sclerosis


subject: MESH:C000710692

object_name: progressive supranuclear palsy


subject: RXCUI:1040052

subject_name: dextromethorphan / quinidine Oral Capsule

object_name: pervasive developmental disorder


subject: RXCUI:1040052

object_name: autism


subject: PUBCHEM.COMPOUND:73455668

subject_name: Oleoyl-estrone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:73455668

object_name: obesity


subject: PUBCHEM.COMPOUND:73455668

object_name: Obesity, CTCAE


subject: UNII:739DM5514X


subject: UNII:739DM5514X


subject: UNII:739DM5514X


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: UNII:0Q8K2L0MC3

subject_name: Olanzapine hydrochloride

object_name: schizophrenia


subject: CHEBI:6121

subject_name: Ketamine

object_name: ventricular septal defect


subject: CHEMBL.COMPOUND:CHEMBL1742993

subject_name: BLOSOZUMAB

object_name: postmenopausal osteoporosis


subject: CHEMBL.COMPOUND:CHEMBL1742993

object_name: osteoporosis


subject: UMLS:C3885232

subject_name: blosozumab


subject: UMLS:C3885232


subject: UMLS:C5417811

subject_name: Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006

object_name: colorectal cancer


subject: UMLS:C5417811

object_name: colorectal carcinoma


subject: UMLS:C5417811

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417811

object_name: non-small cell lung carcinoma


subject: UMLS:C5417811

object_name: pancreatic neoplasm


subject: UMLS:C5417811

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417811

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706552

subject_name: Engineered IL-2 Prodrug WTX-124

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5706552

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: liver carcinoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:68558

object_name: Non-ST Elevation Myocardial Infarction


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: grade III glioma


subject: PUBCHEM.COMPOUND:70789204

object_name: brain neoplasm


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: pancreatic adenocarcinoma


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C5555590

subject_name: ATR Inhibitor ART0380

object_name: Advanced cancer


subject: UMLS:C5555590

object_name: metastatic colorectal cancer


subject: UMLS:C5555590

object_name: endometrial cancer


subject: UMLS:C5555590

object_name: uterine corpus cancer


subject: UMLS:C5555590

object_name: endometrial carcinoma


subject: UMLS:C5555590

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5555590

object_name: primary peritoneal carcinoma


subject: UMLS:C5555590

object_name: Primary Peritoneal Cancer


subject: UMLS:C5555590

object_name: fallopian tube carcinoma


subject: UMLS:C5555590

object_name: fallopian tube cancer


subject: UMLS:C5555590

object_name: acinar cell carcinoma


subject: UMLS:C5555590

object_name: ovarian cancer


subject: UMLS:C5555590

object_name: ovarian neoplasm


subject: UMLS:C5555590

object_name: ovarian carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:567361

subject_name: Cladribine

object_name: adult pulmonary Langerhans cell histiocytosis


subject: CHEBI:521033

subject_name: Dutasteride


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Headache


subject: CHEBI:6129

object_name: Headache, CTCAE


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: uterine fibroid


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:36796

subject_name: duloxetine

object_name: Fragility fracture


subject: CHEBI:36796

object_name: Depression in old age


subject: UNII:0709BVY57W

object_name: Parkinson disease


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Rhizarthrosis


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: esophageal cancer


subject: UMLS:C0935868

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0935868

object_name: neoplasm of esophagus


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: thyroid disease


subject: CHEBI:3215

subject_name: Bupivacaine


subject: UMLS:C3463871

subject_name: Allergen (brand of antipyrine/benzocaine)

object_name: asthma


subject: UMLS:C3463871

object_name: atopic conjunctivitis


subject: UMLS:C3463871

object_name: Atopic rhinitis


subject: UMLS:C3463871

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C3274161

subject_name: Allergen (brand of diphenylpyraline)


subject: UMLS:C3274161


subject: UMLS:C3274161


subject: UMLS:C3274161


subject: MESH:D000485

subject_name: Allergens


subject: MESH:D000485


subject: MESH:D000485


subject: MESH:D000485


subject: UMLS:C0113572

object_name: Androgen excess


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ARID1A gene mutation


subject: CHEBI:30879

subject_name: alcohol

object_name: bariatric surgery candidate


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:79699

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: digestive system disorder


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C4704764

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4704764

object_name: B-cell neoplasm


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Burn injury


subject: PUBCHEM.COMPOUND:6096882

object_name: Burns and Wounds


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: Stomach cancer


subject: UniProtKB:P53767

object_name: gastric cancer


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: PR:000002112


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Urinary Urgency


subject: CHEBI:15377

subject_name: Water


subject: PUBCHEM.COMPOUND:9964861

subject_name: PRAMIPEXOLE HCl

object_name: Restless legs


subject: CHEBI:51147

subject_name: pramipexole hydrochloride


subject: CHEBI:82339

subject_name: Merphalan

object_name: prolymphocytic leukemia


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:31824

subject_name: Mesna

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:31824

object_name: chronic myelomonocytic leukemia


subject: CHEBI:31824

object_name: myeloproliferative neoplasm


subject: CHEBI:31824

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: liver carcinoma


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C0723213

subject_name: Santyl

object_name: diabetic foot


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Metastatic non-small cell lung cancer


subject: UNII:CWG62Q1VTB

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:CWG62Q1VTB

object_name: CD274 Gene Mutation


subject: UNII:CWG62Q1VTB

object_name: lung neoplasm


subject: UNII:CWG62Q1VTB

object_name: lung disorder


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:38290

object_name: Fatigue


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: peritoneum cancer


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: fallopian tube carcinoma


subject: UNII:PVI5M0M1GW

object_name: fallopian tube cancer


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:32599

object_name: Arthritis of knee


subject: CHEBI:25567

subject_name: Nitrous acid

object_name: Heart failure with normal ejection fraction


subject: CHEBI:25567

object_name: Exercise intolerance


subject: CHEBI:25567

object_name: heart disorder


subject: CHEBI:25567

object_name: pulmonary hypertension


subject: CHEBI:25567

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:16301

subject_name: Nitrite


subject: CHEBI:16301


subject: CHEBI:16301


subject: CHEBI:16301


subject: CHEBI:16301


subject: CHEBI:44915

subject_name: Propofol

object_name: myocardial infarction


subject: CHEBI:44915

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:44915

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: Adherence To Medication Regime


subject: CHEBI:52763


subject: CHEBI:63577

subject_name: Lamivudine


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UMLS:C1452313

subject_name: CBG brand of calcium gluconate


subject: PR:000007869

subject_name: cytosolic beta-glucosidase


subject: PR:000014686

subject_name: corticosteroid-binding globulin


subject: UMLS:C0040643

subject_name: Transcortin


subject: UMLS:C5239410

subject_name: CBD Oil


subject: UNII:L1R0M8P1GD

object_name: colon carcinoma


subject: UNII:L1R0M8P1GD

object_name: colon cancer


subject: UMLS:C4684846

subject_name: Anti-Caprin-1 Monoclonal Antibody TRK-950


subject: UMLS:C4684846


subject: CHEBI:8346

subject_name: Potassium Iodide

object_name: Childhood Neuroblastoma


subject: CHEBI:8346

object_name: neuroblastoma


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Stress fracture of tibia or fibula


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: inherited retinal dystrophy


subject: PUBCHEM.COMPOUND:54675783

object_name: retinal disease


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: disease related to transplantation


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: Traveler's diarrhea


subject: CHEBI:261649

object_name: Antibiotic resistant infection


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin

object_name: premenstrual tension


subject: PUBCHEM.COMPOUND:147740

object_name: polydactyly-myopia syndrome


subject: UMLS:C0939533


subject: UMLS:C0939533


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: bone cancer


subject: UNII:6XC1PAD3KF

object_name: bone neoplasm


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline

object_name: preretinal fibrosis


subject: UMLS:C0003209

subject_name: Anti-Inflammatory Agents


subject: UNII:3VF7K7Z10B

object_name: Pruritus


subject: CHEMBL.COMPOUND:CHEMBL3707398


subject: PUBCHEM.COMPOUND:73357808

subject_name: Flutiform

object_name: chronic obstructive pulmonary disease


subject: UMLS:C4742201

subject_name: flutiform


subject: CHEBI:58097

object_name: trauma to the abdomen


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:84739

object_name: Non-cystic fibrosis bronchiectasis


subject: CHEBI:2637

subject_name: Amikacin


subject: DRUGBANK:DB17845

subject_name: BAX 335

object_name: hemophilia B


subject: DRUGBANK:DB17845

object_name: hemophilia B leyden


subject: UMLS:C5815628


subject: UMLS:C5815628


subject: CHEBI:60802

subject_name: ropivacaine

object_name: childhood malignant neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Nasopharyngeal cancer metastatic


subject: UNII:2S9ZZM9Q9V

object_name: Locally Recurrent Malignant Neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UMLS:C0534628

subject_name: Endostatins

object_name: lung adenocarcinoma


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Rheumatic mitral stenosis


subject: CHEBI:68579

object_name: Mitral stenosis


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Gaming disorder


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:4911

subject_name: Etoposide

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: acute lymphoblastic leukemia


subject: CHEBI:79699

object_name: lymphoblastic lymphoma


subject: CHEBI:79699

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:79699

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Malignant pericardial effusion


subject: CHEBI:114785

object_name: Malignant pleural effusion


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Stress


subject: UNII:54QB00NNRB

subject_name: IRSENONTRINE

object_name: Lewy Bodies


subject: DRUGBANK:DB19044

subject_name: Irsenontrine


subject: CHEBI:64030

subject_name: tetrabenazine

object_name: tardive dyskinesia


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: myelodysplastic syndrome with excess blasts


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:5466794

object_name: Blast Phase


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:45716

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: Heel Spur Syndrome


subject: CHEBI:73527

subject_name: Leu-Ala


subject: CHEBI:33336

subject_name: lanthanum atom


subject: CHEBI:17351

subject_name: Linoleic acid


subject: MESH:C534915

subject_name: NanoBone

object_name: atrophy; edentulous ridge


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Wound Complication


subject: CHEBI:144903

object_name: Wound Complication, CTCAE


subject: CHEBI:144903

object_name: gestational diabetes


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: UMLS:C4744685

object_name: Childhood Breast Carcinoma


subject: UMLS:C4744685

object_name: breast carcinoma


subject: UMLS:C4744685

object_name: breast cancer


subject: UMLS:C4744685

object_name: Adult Solid Neoplasm


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: Low back pain


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: colonic disease


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:184662

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354

object_name: HIV infection


subject: PUBCHEM.COMPOUND:155142

subject_name: Sustanon 250

object_name: Hypotestosteronism


subject: PUBCHEM.COMPOUND:155142

object_name: Encounter due to palliative care


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:681569

object_name: myoclonic dystonia 11


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C0733521


subject: CHEBI:18347

subject_name: Norleucine

object_name: Hot Flashes, CTCAE


subject: CHEBI:18347

object_name: Hot flashes


subject: UMLS:C0028375


subject: UMLS:C0028375


subject: UNII:PY79D6C8RX

subject_name: Crofelemer

object_name: short bowel syndrome


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: non-small cell squamous lung carcinoma


subject: UNII:DNZ11VPY7Q

object_name: pancreatic neoplasm


subject: UNII:DNZ11VPY7Q

object_name: exocrine pancreatic carcinoma


subject: UNII:DNZ11VPY7Q

object_name: malignant pancreatic neoplasm


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: liver failure


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C4725176

subject_name: PEOX-based Polymer Encapsulated Paclitaxel FID-007

object_name: head and neck squamous cell carcinoma


subject: CHEBI:39501

subject_name: trientine

object_name: hypertrophic cardiomyopathy


subject: CHEBI:39501

object_name: Hypertrophic cardiomyopathy without obstruction


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UNII:5S371K6132

object_name: Cervix carcinoma recurrent


subject: UMLS:C3854073

subject_name: Capsaicin 8% patch, per square centimeter

object_name: chronic pain (diagnosis)


subject: UMLS:C3854073

object_name: Chronic pain


subject: CHEBI:63630

subject_name: Tolcapone

object_name: cocaine abuse


subject: UNII:56PS9HY5XI

object_name: iron deficiency anemia


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fractured ankle


subject: CHEBI:3215

object_name: Infiltration


subject: CHEBI:60802

subject_name: ropivacaine


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:92043599

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:92043599

object_name: cancer or benign tumor


subject: CHEBI:135207

subject_name: Clofedanol

object_name: musculoskeletal system cancer


subject: CHEBI:135207

object_name: Thromboembolism


subject: CHEBI:135207

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:135207

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:135207

object_name: sarcoma


subject: CHEBI:135207

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:135207

object_name: soft tissue sarcoma


subject: CHEBI:135207

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: Myelodysplasia


subject: CHEBI:47097

object_name: Myelodysplasia, CTCAE


subject: CHEBI:47097

object_name: chronic myelomonocytic leukemia


subject: CHEBI:9757

subject_name: Tropicamide

object_name: Impaired Vision


subject: CHEBI:8093

subject_name: Phenylephrine


subject: UMLS:C5959260

subject_name: IL-2 Fusion Protein PTX-912

object_name: Childhood Solid Neoplasm


subject: UMLS:C5959260

object_name: Adult Solid Neoplasm


subject: UMLS:C5959260

object_name: Solid Neoplasm


subject: UMLS:C5959260

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5959260

object_name: Embolism, Tumor


subject: UMLS:C5959260

object_name: Neoplasm Metastasis


subject: UMLS:C5959260

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:71582672

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:0V8WFB28CB


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: arteriosclerosis disorder


subject: UMLS:C1550678

object_name: myocardial infarction


subject: UMLS:C1550678

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1550678

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: UMLS:C3854029

subject_name: antiseptics ethanol


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854029


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: gastric diffuse large B-cell lymphoma


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Well adult


subject: CHEBI:32682

subject_name: L-argininium

object_name: Cardiac complication


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C4547731

subject_name: AMG 747

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: Thermal injury


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:T74V9O0Y2W

object_name: Acute migraine


subject: CHEBI:48814

subject_name: Chloral

object_name: Brain conditions NEC in ICD9CM


subject: CHEBI:48814

object_name: Other conditions of brain


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:52CMI0WC3Y

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:52CMI0WC3Y

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:52CMI0WC3Y

object_name: B-cell neoplasm


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: UMLS:C1699394

subject_name: Hylenex

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1699394

object_name: non-Hodgkin lymphoma


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394

object_name: plasma cell myeloma


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: carcinoma of esophagus


subject: CHEBI:28748

object_name: esophageal cancer


subject: CHEBI:28748

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: head and neck cancer


subject: CHEBI:90001

object_name: bronchogenic carcinoma


subject: CHEBI:90001

object_name: soft tissue neoplasm


subject: CHEBI:90001

object_name: lymphoma


subject: CHEBI:90001

object_name: neoplasm


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:48021

subject_name: peptide nucleic acid

object_name: chronic hepatitis B virus infection


subject: CHEBI:48021

object_name: hepatitis B


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: Her2-receptor negative breast cancer


subject: UMLS:C0699320

subject_name: Endoxan

object_name: Myelodysplasia


subject: UMLS:C0699320

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0699320

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0699320

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0699320

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0699320

object_name: acute myeloid leukemia


subject: UMLS:C0700805

subject_name: Fludara


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: CHEMBL.COMPOUND:CHEMBL2146146

subject_name: ATROPINE SULFATE

object_name: Intubation complication


subject: UNII:03J5ZE7KA5


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:15407

subject_name: Ephedrine


subject: CHEBI:44915

subject_name: Propofol


subject: GTOPDB:8297

subject_name: seribantumab

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:8297

object_name: Locally Advanced Malignant Solid Neoplasm


subject: GTOPDB:8297

object_name: pancreatic neoplasm


subject: GTOPDB:8297

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:8297

object_name: malignant pancreatic neoplasm


subject: GTOPDB:8297

object_name: Neck Carcinoma


subject: GTOPDB:8297

object_name: head and neck neoplasm


subject: GTOPDB:8297

object_name: head and neck cancer


subject: GTOPDB:8297

object_name: prostate carcinoma


subject: GTOPDB:8297

object_name: prostate cancer


subject: GTOPDB:8297

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: GTOPDB:8297

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: GTOPDB:8297

object_name: gallbladder cancer


subject: GTOPDB:8297

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: GTOPDB:8297

object_name: Stage III Gallbladder Cancer AJCC v8


subject: GTOPDB:8297

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: GTOPDB:8297

object_name: gallbladder carcinoma


subject: GTOPDB:8297

object_name: carcinoma of esophagus


subject: GTOPDB:8297

object_name: esophageal cancer


subject: GTOPDB:8297

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:8297

object_name: neoplasm of esophagus


subject: GTOPDB:8297

object_name: colorectal cancer


subject: GTOPDB:8297

object_name: colorectal carcinoma


subject: GTOPDB:8297

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:8297

object_name: bile duct carcinoma


subject: GTOPDB:8297

object_name: bile duct cancer


subject: GTOPDB:8297

object_name: cholangiocarcinoma


subject: GTOPDB:8297

object_name: uterine cancer


subject: GTOPDB:8297

object_name: tumor of uterus


subject: GTOPDB:8297

object_name: ovarian cancer


subject: GTOPDB:8297

object_name: ovarian neoplasm


subject: GTOPDB:8297

object_name: ovarian carcinoma


subject: GTOPDB:8297

object_name: bladder tumor


subject: GTOPDB:8297

object_name: urinary bladder carcinoma


subject: GTOPDB:8297

object_name: urinary bladder cancer


subject: GTOPDB:8297

object_name: childhood bladder carcinoma


subject: GTOPDB:8297

object_name: renal carcinoma


subject: GTOPDB:8297

object_name: kidney neoplasm


subject: GTOPDB:8297

object_name: kidney cancer


subject: GTOPDB:8297

object_name: Childhood Breast Carcinoma


subject: GTOPDB:8297

object_name: breast carcinoma


subject: GTOPDB:8297

object_name: breast cancer


subject: GTOPDB:8297

object_name: lung cancer


subject: GTOPDB:8297

object_name: lung neoplasm


subject: GTOPDB:8297

object_name: lung carcinoma


subject: GTOPDB:8297

object_name: malignant soft tissue neoplasm


subject: GTOPDB:8297

object_name: sarcoma


subject: UNII:1N3L70MDFX

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:1N3L70MDFX

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:1N3L70MDFX

object_name: pancreatic neoplasm


subject: UNII:1N3L70MDFX

object_name: exocrine pancreatic carcinoma


subject: UNII:1N3L70MDFX

object_name: malignant pancreatic neoplasm


subject: UNII:1N3L70MDFX

object_name: Neck Carcinoma


subject: UNII:1N3L70MDFX

object_name: head and neck neoplasm


subject: UNII:1N3L70MDFX

object_name: head and neck cancer


subject: UNII:1N3L70MDFX

object_name: prostate carcinoma


subject: UNII:1N3L70MDFX

object_name: prostate cancer


subject: UNII:1N3L70MDFX

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:1N3L70MDFX

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:1N3L70MDFX

object_name: gallbladder cancer


subject: UNII:1N3L70MDFX

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:1N3L70MDFX

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:1N3L70MDFX

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:1N3L70MDFX

object_name: gallbladder carcinoma


subject: UNII:1N3L70MDFX

object_name: carcinoma of esophagus


subject: UNII:1N3L70MDFX

object_name: esophageal cancer


subject: UNII:1N3L70MDFX

object_name: Childhood Esophageal Carcinoma


subject: UNII:1N3L70MDFX

object_name: neoplasm of esophagus


subject: UNII:1N3L70MDFX

object_name: colorectal cancer


subject: UNII:1N3L70MDFX

object_name: colorectal carcinoma


subject: UNII:1N3L70MDFX

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:1N3L70MDFX

object_name: bile duct carcinoma


subject: UNII:1N3L70MDFX

object_name: bile duct cancer


subject: UNII:1N3L70MDFX

object_name: cholangiocarcinoma


subject: UNII:1N3L70MDFX

object_name: uterine cancer


subject: UNII:1N3L70MDFX

object_name: tumor of uterus


subject: UNII:1N3L70MDFX

object_name: ovarian cancer


subject: UNII:1N3L70MDFX

object_name: ovarian neoplasm


subject: UNII:1N3L70MDFX

object_name: ovarian carcinoma


subject: UNII:1N3L70MDFX

object_name: bladder tumor


subject: UNII:1N3L70MDFX

object_name: urinary bladder carcinoma


subject: UNII:1N3L70MDFX

object_name: urinary bladder cancer


subject: UNII:1N3L70MDFX

object_name: childhood bladder carcinoma


subject: UNII:1N3L70MDFX

object_name: renal carcinoma


subject: UNII:1N3L70MDFX

object_name: kidney neoplasm


subject: UNII:1N3L70MDFX

object_name: kidney cancer


subject: UNII:1N3L70MDFX

object_name: Childhood Breast Carcinoma


subject: UNII:1N3L70MDFX

object_name: breast carcinoma


subject: UNII:1N3L70MDFX

object_name: breast cancer


subject: UNII:1N3L70MDFX

object_name: lung cancer


subject: UNII:1N3L70MDFX

object_name: lung neoplasm


subject: UNII:1N3L70MDFX

object_name: lung carcinoma


subject: UNII:1N3L70MDFX

object_name: malignant soft tissue neoplasm


subject: UNII:1N3L70MDFX

object_name: sarcoma


subject: UMLS:C2703144

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C2703144

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C2703144

object_name: pancreatic neoplasm


subject: UMLS:C2703144

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2703144

object_name: malignant pancreatic neoplasm


subject: UMLS:C2703144

object_name: Neck Carcinoma


subject: UMLS:C2703144

object_name: head and neck neoplasm


subject: UMLS:C2703144

object_name: head and neck cancer


subject: UMLS:C2703144

object_name: prostate carcinoma


subject: UMLS:C2703144

object_name: prostate cancer


subject: UMLS:C2703144

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C2703144

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UMLS:C2703144

object_name: gallbladder cancer


subject: UMLS:C2703144

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UMLS:C2703144

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UMLS:C2703144

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C2703144

object_name: gallbladder carcinoma


subject: UMLS:C2703144

object_name: carcinoma of esophagus


subject: UMLS:C2703144

object_name: esophageal cancer


subject: UMLS:C2703144

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2703144

object_name: neoplasm of esophagus


subject: UMLS:C2703144

object_name: bile duct carcinoma


subject: UMLS:C2703144

object_name: bile duct cancer


subject: UMLS:C2703144

object_name: cholangiocarcinoma


subject: UMLS:C2703144

object_name: uterine cancer


subject: UMLS:C2703144

object_name: tumor of uterus


subject: UMLS:C2703144

object_name: ovarian cancer


subject: UMLS:C2703144

object_name: ovarian neoplasm


subject: UMLS:C2703144

object_name: bladder tumor


subject: UMLS:C2703144

object_name: urinary bladder carcinoma


subject: UMLS:C2703144

object_name: urinary bladder cancer


subject: UMLS:C2703144

object_name: childhood bladder carcinoma


subject: UMLS:C2703144

object_name: renal carcinoma


subject: UMLS:C2703144

object_name: kidney neoplasm


subject: UMLS:C2703144

object_name: kidney cancer


subject: UMLS:C2703144

object_name: Childhood Breast Carcinoma


subject: UMLS:C2703144

object_name: breast carcinoma


subject: UMLS:C2703144

object_name: breast cancer


subject: UMLS:C2703144

object_name: lung cancer


subject: UMLS:C2703144

object_name: lung neoplasm


subject: UMLS:C2703144

object_name: lung carcinoma


subject: UMLS:C2703144

object_name: malignant soft tissue neoplasm


subject: UMLS:C2703144

object_name: sarcoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: tumor suppressor gene on chromosome 11


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Brow ptosis


subject: CHEBI:172944

subject_name: Cabotegravir

object_name: Medication Nonadherence


subject: CHEBI:68606

subject_name: Rilpivirine


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: acute lymphoblastic leukemia


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Adverse Event Associated with the Gastrointestinal System


subject: CHEBI:38290

object_name: Digestive System Finding


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:6402

subject_name: Leflunomide

object_name: Symptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:6402

object_name: Malignant Solid Neoplasm


subject: CHEBI:6402

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:6402

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K

object_name: pulmonary coin lesion


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: PR:000005225

subject_name: cell division cycle-associated 7-like protein

object_name: insomnia


subject: PR:000005225

object_name: Insomnia, CTCAE 3.0


subject: PR:000005225

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:78621

subject_name: Monepantel

object_name: motor neuron disorder


subject: PUBCHEM.COMPOUND:9846339

subject_name: Gallium Maltolate

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9846339

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:9846339

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:9846339

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:9846339

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:9846339

object_name: lymphoma


subject: PUBCHEM.COMPOUND:9846339

object_name: pediatric lymphoma


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UMLS:C1327750

subject_name: DCVax-L

object_name: glioblastoma


subject: UMLS:C1327750

object_name: Brain Stem Glioblastoma


subject: UMLS:C1327750

object_name: glioma susceptibility 1


subject: CHEBI:75722

subject_name: Tramadol

object_name: IUD insertion complication


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: carotid stenosis


subject: UMLS:C0085826

object_name: Acute Stroke


subject: UMLS:C0085826

object_name: carotid artery disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Oligoastrocytoma


subject: CHEBI:31355

object_name: oligoastrocytoma


subject: CHEBI:31355

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:31355

object_name: anaplastic oligoastrocytoma


subject: CHEBI:31355

object_name: mixed glioma


subject: CHEBI:31355

object_name: Adult Mixed Glioma


subject: CHEBI:31355

object_name: Childhood Mixed Glioma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:4911

object_name: anaplastic oligodendroglioma


subject: CHEBI:4911

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:16899

subject_name: Mannitol


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malnutrition


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: Premature birth


subject: UMLS:C2608320

object_name: premature birth (history)


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: bruxism


subject: CHEBI:51098

subject_name: Motesanib

object_name: lung cancer


subject: CHEBI:51098

object_name: lung neoplasm


subject: CHEBI:51098

object_name: lung carcinoma


subject: CHEBI:51098

object_name: pancreatic neoplasm


subject: CHEBI:51098

object_name: exocrine pancreatic carcinoma


subject: CHEBI:51098

object_name: malignant pancreatic neoplasm


subject: CHEBI:51098

object_name: carcinoma of esophagus


subject: CHEBI:51098

object_name: esophageal cancer


subject: CHEBI:51098

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:51098

object_name: neoplasm of esophagus


subject: UMLS:C1541476

subject_name: AMG 706


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: CHEMBL.COMPOUND:CHEMBL4594466

subject_name: PEGOZAFERMIN


subject: UMLS:C5707936

subject_name: Pegozafermin


subject: PR:000006163

subject_name: zinc finger protein castor homolog 1


subject: PR:000007807

subject_name: galactosylceramide sulfotransferase


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: neoplastic meningitis


subject: UMLS:C0733521

subject_name: Ara-C


subject: CHEBI:90881

subject_name: Camptosar

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:90881

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C2347328

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Recurrent Childhood Pilocytic Astrocytoma


subject: CHEBI:63791

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:63791

object_name: neurofibromatosis 1


subject: CHEBI:63791

object_name: neurofibromatosis type 1


subject: CHEBI:48923

subject_name: erythromycin

object_name: Respiratory Aspiration of Gastric Contents


subject: CHEBI:48923

object_name: recent aspiration of gastric contents (history)


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: Large adenoids


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate


subject: CHEBI:6970

subject_name: Mometasone


subject: UNII:XH93U6NIJE

object_name: cancer


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:66919

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:66919

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: end stage renal failure


subject: CHEBI:135915

object_name: Chronic uremia


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: adult hepatocellular carcinoma


subject: UNII:GKF8S4C432

object_name: pediatric hepatocellular carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989

object_name: liver cancer


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:25187

subject_name: Menthol

object_name: Chronic low back pain


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Drug-induced obesity


subject: CHEBI:15365

subject_name: Aspirin

object_name: ischemia


subject: CHEBI:15365

object_name: cerebral infarction


subject: UMLS:C5139948

object_name: major depressive disorder


subject: UMLS:C3859491

subject_name: Trumenba

object_name: gonorrhea


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: sclerosing cholangitis


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: diabetes mellitus


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: Compulsion


subject: MESH:C000718012

subject_name: sucrosomial iron

object_name: ulcerative colitis


subject: MESH:C000718012

object_name: inflammatory bowel disease 1


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: UNII:UM2XKY25DH

subject_name: NORELGESTROMIN

object_name: Metrorrhagia


subject: UNII:UM2XKY25DH

object_name: heavy bleeding between periods (symptom)


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:13304

object_name: malignant neoplasm of breast stage IV


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: CHEBI:84040

object_name: chronic kidney disease


subject: CHEBI:84040

object_name: Chronic uremia


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: endometrial cancer


subject: CHEBI:39548

object_name: uterine corpus cancer


subject: CHEBI:39548

object_name: endometrial carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Skin-picking


subject: CHEBI:28939

object_name: neurotic excoriation


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: sleep disorder


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: breast neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:39548

object_name: cancer


subject: CHEBI:39548

object_name: neoplasm


subject: PUBCHEM.COMPOUND:6323481

subject_name: phosphatidylserine

object_name: Riley-Day syndrome


subject: KEGG.COMPOUND:C02737

subject_name: Phosphatidylserine


subject: CHEBI:18303


subject: PUBCHEM.COMPOUND:6096882

object_name: Breast Cancer Lymphedema


subject: UNII:C4V974V932


subject: CHEBI:8988

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C0085155

subject_name: Generic Drugs

object_name: hypertension


subject: UMLS:C0085155

object_name: Hypertension, CTCAE


subject: UMLS:C5666953

subject_name: Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HLX301

object_name: non-small cell lung carcinoma


subject: UMLS:C1328149

object_name: colorectal neoplasm


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:94782

subject_name: Cediranib

object_name: Germline BRCA2 Gene Mutation


subject: CHEBI:94782

object_name: Germline BRCA1 Gene Mutation


subject: CHEBI:94782

object_name: Advanced Breast Carcinoma


subject: CHEBI:94782

object_name: Metastatic Breast Carcinoma


subject: CHEBI:94782

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:94782

object_name: HER2/Neu Negative


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:10362

subject_name: Cryptoxanthin

object_name: postmenopausal disorder


subject: PUBCHEM.COMPOUND:86821


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:90942

subject_name: Ixazomib

object_name: autoimmune thrombocytopenia


subject: CHEBI:90942

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:90942

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:90942

object_name: autoimmune hemolytic anemia, warm type


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Allergy


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: periampullary adenocarcinoma


subject: PUBCHEM.COMPOUND:86821

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:86821

object_name: coronary atherosclerosis


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:2549

subject_name: Albuterol

object_name: Wheezing


subject: CHEBI:2549

object_name: Wheezing, CTCAE


subject: UNII:3BY9Z3M34G

subject_name: Golidocitinib


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: colon carcinoma


subject: UNII:DPT0O3T46P

object_name: colon cancer


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:231598

object_name: Metastatic urothelial carcinoma


subject: CHEBI:231598

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:231598

object_name: Stage IV Bladder Cancer AJCC v8


subject: UMLS:C4305720

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4305720

object_name: obesity


subject: UMLS:C4305720

object_name: Obesity, CTCAE


subject: UMLS:C1541526

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:44915

subject_name: Propofol

object_name: Hypotension on induction


subject: CHEBI:44915

object_name: Hypnotic intoxication


subject: UMLS:C0304483

subject_name: Fat emulsion

object_name: Advanced cancer


subject: CHEBI:31498

subject_name: Simethicone

object_name: gastric neoplasm


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: head and neck squamous cell carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: ovarian cancer


subject: CHEBI:145421

object_name: ovarian neoplasm


subject: CHEBI:145421

object_name: ovarian carcinoma


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C2347619


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: metastatic neoplasm


subject: UMLS:C4083270

object_name: Embolism, Tumor


subject: UMLS:C4083270

object_name: Neoplasm Metastasis


subject: UMLS:C4083270

object_name: Metastatic Lesion


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:91400


subject: CHEBI:91400


subject: PUBCHEM.COMPOUND:10458325

subject_name: tesevatinib

object_name: neoplastic meningitis


subject: PUBCHEM.COMPOUND:10458325

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:10458325

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:167674

subject_name: Tesevatinib


subject: CHEBI:167674


subject: CHEBI:167674


subject: UMLS:C0592547

subject_name: Movicol

object_name: liver disorder


subject: UMLS:C0723575

subject_name: T-Diet

object_name: Mechanical ventilation complication


subject: UMLS:C0723575

object_name: Metabolic stress hyperglycemia


subject: UMLS:C0723575

object_name: Critical Illness


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: alcohol consumption (history)


subject: UMLS:C5779650


subject: CHEBI:3547

subject_name: Cefradine

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:3547

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:4026

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:4026

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Hallux valgus


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: mucocutaneous lymph node syndrome


subject: CHEBI:47781

subject_name: Desipramine

object_name: anxiety disorder


subject: CHEBI:47781

object_name: personality disorder


subject: UMLS:C5908017

subject_name: PRMT5 Inhibitor AZD3470

object_name: Hodgkin Disease


subject: UMLS:C5908017

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5908017

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5908017

object_name: adult lymphoma


subject: UMLS:C5908017

object_name: lymphoma


subject: UMLS:C5908017

object_name: pediatric lymphoma


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: bipolar II disorder


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:64312

subject_name: Memantine


subject: UMLS:C5854467

subject_name: Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978

object_name: Sicca Syndrome


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: acute coronary syndrome


subject: CHEBI:83314

subject_name: vorapaxar sulfate


subject: UMLS:C2974522


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: HIV infection


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C5943207

object_name: age-related macular degeneration


subject: CHEBI:29998

subject_name: D-serine residue

object_name: schizophrenia 18


subject: CHEBI:17115

subject_name: Serine


subject: UMLS:C1880218

subject_name: serine, D-


subject: UNII:YP8G3I74EL

subject_name: Vorolanib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:52172

subject_name: Nilotinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:52172

object_name: acute myeloid leukemia


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: Eventration


subject: CHEBI:36333

object_name: omphalocele


subject: CHEBI:36333

object_name: gastroschisis


subject: CHEBI:36333

object_name: Hernia of the abdominal wall


subject: CHEBI:36333

object_name: Hernia


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C0499161

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C0499161

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: CHEMBL.COMPOUND:CHEMBL4650442

object_name: Huntington disease


subject: UMLS:C5705578


subject: CHEBI:119915

subject_name: Fentanyl

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: myelofibrosis


subject: UMLS:C4287812

subject_name: ulixertinib


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: Fatty Liver


subject: CHEBI:43602

object_name: steatosis


subject: CHEBI:144943

object_name: bacterial infectious disease


subject: CHEBI:75539

subject_name: monolaurin


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: malignant urinary system neoplasm


subject: PUBCHEM.COMPOUND:6012

object_name: urinary system disorder


subject: PUBCHEM.COMPOUND:6012

object_name: urinary system neoplasm


subject: PUBCHEM.COMPOUND:6012

object_name: hypogonadism


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:9241

subject_name: Spironolactone

object_name: arteriosclerosis disorder


subject: CHEBI:9241

object_name: atherosclerosis


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Advanced Esophageal Carcinoma


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEMBL.COMPOUND:CHEMBL2109256

object_name: Childhood Large Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2109256

object_name: reticulosarcoma


subject: UMLS:C1328236

subject_name: BRENTUXIMAB


subject: UMLS:C1328236


subject: UNII:3GBO34D1BE

object_name: Parkinson disease


subject: UMLS:C5447559

subject_name: Lenrispodun


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Primary malignant neoplasm


subject: UMLS:C0770694

object_name: cancer


subject: UMLS:C0770694

object_name: childhood malignant neoplasm


subject: UMLS:C0770694

object_name: Malignant obstetric neoplasm


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: Chronic uremia


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C4733628

object_name: dry eye syndrome


subject: UMLS:C4733628

object_name: Dry Eye, CTCAE


subject: UMLS:C4733628

object_name: Dryness of eye


subject: UMLS:C4733628

object_name: eyes dry chronic


subject: UMLS:C3827159

subject_name: CMVpp65/gB Plasmid Vaccine ASP0113

object_name: cytomegalovirus infection


subject: GTOPDB:13305

subject_name: linvoseltamab

object_name: monoclonal gammopathy of uncertain significance


subject: UNII:M3CPC50MZS

subject_name: LINVOSELTAMAB


subject: UMLS:C4764258

subject_name: Linvoseltamab


subject: CHEBI:7575

subject_name: Nimodipine

object_name: Postseizure delirium


subject: CHEBI:7575

object_name: epilepsy


subject: CHEBI:7575

object_name: Depressed mood


subject: CHEBI:7575

object_name: Cancer patients and suicide and depression


subject: CHEBI:7575

object_name: Depressed - symptom


subject: CHEBI:7575

object_name: Depression, CTCAE


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: UNII:3HO3IZ2ILX

object_name: chronic diabetic kidney disease


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Nonulcer dyspepsia


subject: CHEBI:6375

object_name: Chronic primary epigastric pain syndrome


subject: CHEBI:6375

object_name: Postprandial distress syndrome


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: sudden hearing loss disorder


subject: UMLS:C5854465

subject_name: Anti-FRa Antibody-drug Conjugate AZD5335

object_name: ovarian carcinoma


subject: UMLS:C5854465

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:129049969

subject_name: tegileridine

object_name: adolescent idiopathic scoliosis


subject: UNII:YFJS8L4TGU

subject_name: TEGILERIDINE


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: Intermetatarsal bursitis


subject: UMLS:C2095490

object_name: rheumatoid arthritis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Sepsis


subject: CHEBI:41879

object_name: Sepsis, CTCAE


subject: UMLS:C3896848

object_name: non-small cell lung carcinoma


subject: UMLS:C3896848

object_name: melanoma


subject: UNII:7N13IK9LNH

object_name: Metastatic Colorectal Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Colorectal Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced gastric carcinoma


subject: UNII:7N13IK9LNH

object_name: Metastatic Gastric Carcinoma


subject: UNII:7N13IK9LNH

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UNII:7N13IK9LNH

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Metastatic Digestive System Carcinoma


subject: UNII:7N13IK9LNH

object_name: Advanced Digestive System Carcinoma


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988